Prostate cancer decisions — 2026

The Veteran's claims for service connection are being remanded due to a duty to assist error in not obtaining opinions addressing all of the Veteran's toxic exposure risk activities, including garrison exposures. The Board finds that there is sufficient information to establish participation in Toxic Exposure Risk Activities (TERA) through garrison exposure and thus a pre-decisional duty to assist error occurred.

The Board has dismissed the appeals for bilateral hearing loss and tinnitus as they were withdrawn by the Veteran's representative. The claims of service connection for a bilateral eye disability, prostate cancer, skin cancer, left knee disability, right knee disability, cardiovascular disability, and headaches are being remanded due to pre-decisional duty to assist errors.

The Veteran's appeal for a compensable rating for residual scars as a result of squamous cell carcinoma of the hands and lower extremities is dismissed because it was previously addressed in another decision.,The Veteran's claim for service connection for squamous cell carcinoma (claimed as non-melanoma skin cancer) is dismissed because his claim was granted by a prior Board decision.

The Board has denied the Veteran's appeal regarding the reduction of his prostate cancer rating from 100% to 40%, and granted a 60% rating for residuals of prostate cancer effective July 1, 2020.

The Board has granted the restoration of service connection for prostate cancer residuals and erectile dysfunction, effective October 1, 2025. The severance was improper due to the presumption of herbicide exposure.

The Board has remanded the veteran's claims for prostate cancer and osteoporosis of the spine due to exposure to contaminated water at Camp Lejeune. The appellant is seeking service connection for these conditions, which are presumed based on their association with toxic exposure during military service.

The Board has decided to remand the Veteran's claim for prostate cancer as it requires a VA examination and medical opinion due to the PACT Act, which mandates such an examination when a Veteran submits a compensation claim and has evidence of participation in a toxic exposure risk activity (TERA) but not sufficient to establish service connection.

The Board has granted service connection for erectile dysfunction as secondary to the Veteran's service-connected prostate cancer and SMC based on loss of use of a creative organ. The decision is in favor of the Veteran.

The Board has determined that the severance of service connection for coronary artery disease with atrial fibrillation, hypertension, and prostate cancer with voiding dysfunction was improper due to lack of clear and unmistakable error in the original grant of service connection based on herbicide exposure. The appeal is granted.

The Veteran's claims for service connection for prostate cancer, hearing loss, left ankle disability, right ankle disability, left shoulder disability, and right shoulder disability are remanded due to a failure to provide the Veteran with VA examinations prior to adjudication of his claims.

The Veteran withdrew his appeal for a higher rating for prostate cancer at the November 2025 hearing, and the Board dismissed the appeal.

The Veteran's prostate cancer residuals with radical retro pubic prostatectomy residuals are rated at 60 percent effective August 28, 2017. The TDIU is granted on an extraschedular basis prior to this date.

The appeal for a TDIU based on prostate cancer and PTSD was denied in the September 2012 rating decision, which became final due to lack of timely appeal. The Veteran's combined disability rating decreased from 100% to 90%.

The Board denied the Veteran's claims for discontinuance of the 100% evaluation for prostate cancer and entitlement to a higher disability rating for prostate cancer residuals, finding that the evidence did not support ratings in excess of 40 percent.

The Board has determined that the reduction of your prostate cancer rating from 100% to 20% was proper and denied a restoration of the 100% rating.

The Veteran's claim for specially adapted housing and/or a special home adaptation grant is being remanded due to the need for further examination to determine his eligibility based on service-connected disabilities.

The Board has remanded the Veteran's claims for service connection due to credibility issues with his testimony and lack of supporting medical evidence. The case is being returned for additional development, including obtaining records from the Army National Guard period, left knee surgery records, clarification on TERA exposure details, and a new opinion regarding prostate cancer.

The Board dismissed the appeal as the proposed severance of service connection for prostate cancer and myelofibrosis was not a final decision, and thus premature.

The Veteran's prostate cancer is related to his in-service exposure to ionizing radiation, and the Board finds that service connection for this condition is granted.

The Veteran was granted a 60 percent rating for prostate cancer residuals from December 1, 2013 to February 11, 2021. The Board found that the Veteran required absorbent materials changing more than four times per day due to bladder dysfunction.